On May 31, the "Integrating Medicine and Care, Innovating for the Future" Demyelinating Disease Patient-Physician Exchange Day, jointly organized by Huashan Hospital Affiliated to Fudan University and the Care for Rare Rare Disease Support Center, and fully supported by Sino Universal Pharma, was successfully held at Huashan Garden, Huashan Hospital in Shanghai.
Lighting Up Hope: Multidisciplinary Experts Guard the Science Classroom
This event focused on neuroimmune rare diseases such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It brought together multidisciplinary authoritative experts from departments including neurology, rehabilitation, ophthalmology, and integrated traditional Chinese and Western medicine, in collaboration with the Shanghai Society for Immunology, Zhoushan Municipal Health Commission, and the Shanghai Center for Drug Evaluation and Inspection. Through activities such as science lectures, multidisciplinary consultations, roundtable discussions, and humanistic therapy, the event provided full-cycle health support to nearly 100 patients and their families, lighting up the path of hope for the rare disease community with professionalism and warmth.
At the event, authoritative experts used clear and accessible language to explain key topics such as identifying disease relapse, infection prevention and control, rehabilitation management, and integrated traditional Chinese and Western medicine diagnosis and treatment, helping to break down information barriers for patients.
Breaking the Cocoon · Moving Toward Healing: Exploring the New Future of Diagnosis and Treatment Together
The future of rare diseases lies in collaboration. The "Breaking the Cocoon · Moving Toward Healing" roundtable dialogue brought together representatives from clinical practice, scientific research, regulatory authorities, and industry. Focusing on key directions such as precision diagnosis, clinical research, medical AI, drug accessibility, and patient support, the discussion explored innovative pathways for the diagnosis and treatment of demyelinating diseases, rallying cross-sector synergy to drive breakthroughs in rare disease care.
Warm-Hearted Care, Illuminating the Path Forward for Patients
Multidisciplinary experts provided one-on-one consultations, offering exclusive services such as free disease assessment, treatment plan optimization, and rehabilitation guidance. With meticulous care and patience, they addressed patients' medical challenges and enabled the rare disease community to feel genuine support and compassion.
Walking Together for Love: Sino Universal Pharma Fulfills Its Social Mission Through Public Welfare
In the world of neuroimmune rare diseases, behind every confirmed diagnosis lies a long and arduous journey for an entire family. Sino Universal Pharma deeply understands that treating rare diseases requires not only cutting-edge medicines but also an integrated ecosystem encompassing medical care, rehabilitation, psychological support, and social services.
From drug introduction to public welfare engagement, from clinical support to patient care, Sino Universal Pharma consistently upholds the heart of a healer and the sense of social responsibility. Guided by clinical needs and centered on patients, the company walks hand in hand with caring forces from all sectors of society. In the future, Sino Universal Pharma will continue to serve as a transmitter of "light" in the rare disease field, harnessing the power of innovative medicine and the spirit of public welfare to support every rare disease patient in growing toward the sun and moving forward with hope—ensuring that each step leads toward a life of autonomy, warmth, and promise.
